96 related articles for article (PubMed ID: 19515063)
1. Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells.
Nakayama H; Zhao J; Ei-Fakhrany A; Isosaki M; Satoh H; Kyotani Y; Yoshizumi M
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1183-5. PubMed ID: 19515063
[TBL] [Abstract][Full Text] [Related]
2. Pramipexole protects against H2O2-induced PC12 cell death.
Fujita Y; Izawa Y; Ali N; Kanematsu Y; Tsuchiya K; Hamano S; Tamaki T; Yoshizumi M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):257-66. PubMed ID: 16362428
[TBL] [Abstract][Full Text] [Related]
3. Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.
Ling ZD; Robie HC; Tong CW; Carvey PM
J Pharmacol Exp Ther; 1999 Apr; 289(1):202-10. PubMed ID: 10087005
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of water extract of Panax ginseng on corticosterone-induced apoptosis in PC12 cells and its underlying molecule mechanisms.
Jiang Y; Li Z; Liu Y; Liu X; Chang Q; Liao Y; Pan R
J Ethnopharmacol; 2015 Jan; 159():102-12. PubMed ID: 25446601
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons.
Du F; Li R; Huang Y; Li X; Le W
Eur J Neurosci; 2005 Nov; 22(10):2422-30. PubMed ID: 16307585
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of nicotine on tunicamycin-induced apoptosis of PC12h cells.
Utsumi T; Shimoke K; Kishi S; Sasaya H; Ikeuchi T; Nakayama H
Neurosci Lett; 2004 Nov; 370(2-3):244-7. PubMed ID: 15488331
[TBL] [Abstract][Full Text] [Related]
7. Distinct effects of pramipexole on the proliferation of adult mouse sub-ventricular zone-derived cells and the appearance of a neuronal phenotype.
Merlo S; Canonico PL; Sortino MA
Neuropharmacology; 2011 May; 60(6):892-900. PubMed ID: 21272591
[TBL] [Abstract][Full Text] [Related]
8. Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.
Chang WL; Breier MR; Yang A; Swerdlow NR
Pharmacol Biochem Behav; 2011 Oct; 99(4):634-8. PubMed ID: 21683731
[TBL] [Abstract][Full Text] [Related]
9. Involvement of dopamine D(2)/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells.
Presgraves SP; Borwege S; Millan MJ; Joyce JN
Exp Neurol; 2004 Nov; 190(1):157-70. PubMed ID: 15473989
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of total saikosaponins of Bupleurum yinchowense on corticosterone-induced apoptosis in PC12 cells.
Li ZY; Guo Z; Liu YM; Liu XM; Chang Q; Liao YH; Pan RL
J Ethnopharmacol; 2013 Jul; 148(3):794-803. PubMed ID: 23694845
[TBL] [Abstract][Full Text] [Related]
11. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
[TBL] [Abstract][Full Text] [Related]
12. Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture.
Reichelt D; Radad K; Moldzio R; Rausch WD; Reichmann H; Gille G
CNS Neurol Disord Drug Targets; 2016; 15(10):1325-1332. PubMed ID: 27488420
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
Zou L; Jankovic J; Rowe DB; Xie W; Appel SH; Le W
Life Sci; 1999; 64(15):1275-85. PubMed ID: 10227583
[TBL] [Abstract][Full Text] [Related]
14. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain.
Chernoloz O; El Mansari M; Blier P
Neuropsychopharmacology; 2009 Feb; 34(3):651-61. PubMed ID: 18688211
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective activity of Viola mandshurica extracts on hydrogen peroxide-induced DNA damage and cell death in PC12 cells.
Jeon GI; Yoon MY; Park HR; Lee SC; Park E
Ann N Y Acad Sci; 2009 Aug; 1171():576-82. PubMed ID: 19723107
[TBL] [Abstract][Full Text] [Related]
16. Reinforcing properties of Pramipexole in normal and parkinsonian rats.
Engeln M; Ahmed SH; Vouillac C; Tison F; Bezard E; Fernagut PO
Neurobiol Dis; 2013 Jan; 49():79-86. PubMed ID: 22940424
[TBL] [Abstract][Full Text] [Related]
17. Pramipexole attenuates the dopaminergic cell loss induced by intraventricular 6-hydroxydopamine.
Vu TQ; Ling ZD; Ma SY; Robie HC; Tong CW; Chen EY; Lipton JW; Carvey PM
J Neural Transm (Vienna); 2000; 107(2):159-76. PubMed ID: 10847557
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid (DHA) has neuroprotective effects against oxidative stress in retinal ganglion cells.
Shimazawa M; Nakajima Y; Mashima Y; Hara H
Brain Res; 2009 Jan; 1251():269-75. PubMed ID: 19056360
[TBL] [Abstract][Full Text] [Related]
19. Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
Lieberknecht V; Junqueira SC; Cunha MP; Barbosa TA; de Souza LF; Coelho IS; Santos AR; Rodrigues AL; Dafré AL; Dutra RC
Mol Neurobiol; 2017 Mar; 54(2):1033-1045. PubMed ID: 26801190
[TBL] [Abstract][Full Text] [Related]
20. Regulation of intracellular dopamine levels by dopaminergic drugs: involvement of vesicular monoamine transporter.
Izumi Y; Yamamoto N; Kume T; Katsuki H; Sawada H; Akaike A
Eur J Pharmacol; 2008 Mar; 582(1-3):52-61. PubMed ID: 18261722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
